Global Insulin Like Growth Factor 1 Receptor Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Insulin Like Growth Factor 1 Receptor
- 1.1 Definition of Insulin Like Growth Factor 1 Receptor
- 1.2 Insulin Like Growth Factor 1 Receptor Segment by Type
- 1.2.1 Global Insulin Like Growth Factor 1 Receptor Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 BI-893923
- 1.2.3 CT-707
- 1.2.4 1R-E1
- 1.2.5 ATL-1101
- 1.2.6 Others
- 1.3 Insulin Like Growth Factor 1 Receptor Segment by Applications
- 1.3.1 Global Insulin Like Growth Factor 1 Receptor Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Insulin Like Growth Factor 1 Receptor Overall Market
- 1.4.1 Global Insulin Like Growth Factor 1 Receptor Revenue (2014-2025)
- 1.4.2 Global Insulin Like Growth Factor 1 Receptor Production (2014-2025)
- 1.4.3 North America Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
- 1.4.4 Europe Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
- 1.4.5 China Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
- 1.4.6 Japan Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
- 1.4.8 India Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Insulin Like Growth Factor 1 Receptor
- 2.3 Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor
- 2.4 Industry Chain Structure of Insulin Like Growth Factor 1 Receptor
3 Development and Manufacturing Plants Analysis of Insulin Like Growth Factor 1 Receptor
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Insulin Like Growth Factor 1 Receptor Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Insulin Like Growth Factor 1 Receptor
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Insulin Like Growth Factor 1 Receptor Production and Capacity Analysis
- 4.2 Insulin Like Growth Factor 1 Receptor Revenue Analysis
- 4.3 Insulin Like Growth Factor 1 Receptor Price Analysis
- 4.4 Market Concentration Degree
5 Insulin Like Growth Factor 1 Receptor Regional Market Analysis
- 5.1 Insulin Like Growth Factor 1 Receptor Production by Regions
- 5.1.1 Global Insulin Like Growth Factor 1 Receptor Production by Regions
- 5.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Regions
- 5.2 Insulin Like Growth Factor 1 Receptor Consumption by Regions
- 5.3 North America Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.3.1 North America Insulin Like Growth Factor 1 Receptor Production
- 5.3.2 North America Insulin Like Growth Factor 1 Receptor Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Insulin Like Growth Factor 1 Receptor Import and Export
- 5.4 Europe Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.4.1 Europe Insulin Like Growth Factor 1 Receptor Production
- 5.4.2 Europe Insulin Like Growth Factor 1 Receptor Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Insulin Like Growth Factor 1 Receptor Import and Export
- 5.5 China Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.5.1 China Insulin Like Growth Factor 1 Receptor Production
- 5.5.2 China Insulin Like Growth Factor 1 Receptor Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Insulin Like Growth Factor 1 Receptor Import and Export
- 5.6 Japan Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.6.1 Japan Insulin Like Growth Factor 1 Receptor Production
- 5.6.2 Japan Insulin Like Growth Factor 1 Receptor Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Insulin Like Growth Factor 1 Receptor Import and Export
- 5.7 Southeast Asia Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.7.1 Southeast Asia Insulin Like Growth Factor 1 Receptor Production
- 5.7.2 Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Insulin Like Growth Factor 1 Receptor Import and Export
- 5.8 India Insulin Like Growth Factor 1 Receptor Market Analysis
- 5.8.1 India Insulin Like Growth Factor 1 Receptor Production
- 5.8.2 India Insulin Like Growth Factor 1 Receptor Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Insulin Like Growth Factor 1 Receptor Import and Export
6 Insulin Like Growth Factor 1 Receptor Segment Market Analysis (by Type)
- 6.1 Global Insulin Like Growth Factor 1 Receptor Production by Type
- 6.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type
- 6.3 Insulin Like Growth Factor 1 Receptor Price by Type
7 Insulin Like Growth Factor 1 Receptor Segment Market Analysis (by Application)
- 7.1 Global Insulin Like Growth Factor 1 Receptor Consumption by Application
- 7.2 Global Insulin Like Growth Factor 1 Receptor Consumption Market Share by Application (2014-2019)
8 Insulin Like Growth Factor 1 Receptor Major Manufacturers Analysis
- 8.1 Astellas Pharma Inc.
- 8.1.1 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
- 8.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 AstraZeneca Plc
- 8.2.1 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.2.2 AstraZeneca Plc Product Introduction, Application and Specification
- 8.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Axelar AB
- 8.3.1 Axelar AB Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.3.2 Axelar AB Product Introduction, Application and Specification
- 8.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Boehringer Ingelheim GmbH
- 8.4.1 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.4.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
- 8.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Bristol-Myers Squibb Company
- 8.5.1 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.5.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
- 8.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Eli Lilly and Company
- 8.6.1 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 F. Hoffmann-La Roche Ltd.
- 8.7.1 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.7.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
- 8.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Genmab A/S
- 8.8.1 Genmab A/S Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.8.2 Genmab A/S Product Introduction, Application and Specification
- 8.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Immunomedics, Inc.
- 8.9.1 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.9.2 Immunomedics, Inc. Product Introduction, Application and Specification
- 8.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Insmed Incorporated
- 8.10.1 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 8.10.2 Insmed Incorporated Product Introduction, Application and Specification
- 8.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Merck & Co., Inc.
- 8.12 Merrimack Pharmaceuticals, Inc.
- 8.13 Novartis AG
- 8.14 PharmAbcine, Inc.
- 8.15 ProteoThera, Inc.
9 Development Trend of Analysis of Insulin Like Growth Factor 1 Receptor Market
- 9.1 Global Insulin Like Growth Factor 1 Receptor Market Trend Analysis
- 9.1.1 Global Insulin Like Growth Factor 1 Receptor Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Insulin Like Growth Factor 1 Receptor Regional Market Trend
- 9.2.1 North America Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.2.2 Europe Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.2.3 China Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.2.4 Japan Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.2.5 Southeast Asia Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.2.6 India Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
- 9.3 Insulin Like Growth Factor 1 Receptor Market Trend (Product Type)
- 9.4 Insulin Like Growth Factor 1 Receptor Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Insulin Like Growth Factor 1 Receptor Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Insulin Like Growth Factor 1 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Insulin Like Growth Factor 1 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Like Growth Factor 1 Receptor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Like Growth Factor 1 Receptor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Like Growth Factor 1 Receptor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Astellas Pharma Inc.
AstraZeneca Plc
Axelar AB
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Genmab A/S
Immunomedics, Inc.
Insmed Incorporated
Merck & Co., Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
PharmAbcine, Inc.
ProteoThera, Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
BI-893923
CT-707
1R-E1
ATL-1101
Others
Segment by Application
Hospital
Clinic
Others